Figures
In the first paragraph of the Results section, there is an error in the penultimate sentence. Please see the corrected sentence below:
“The average blood riboflavin level in high tumor stage patients ( ≥IIb) was 182.01±89.43 ug/L, which was significantly lower than in patients with low tumor stage ≤IIa(277.25±34.56 ug/L)."
There is an error in the Figure 3 legend. Please see the figure and the corrected legend below:
A, Representative results of C20orf54 and β-tubulin protein was described in CSCC (T) and matched normal tissues (N) by western blot. B, Representative results of C20orf54 and β-actin mRNA was examined in CSCC (T) and corresponding normal tissues (N) by qRT-PCR. C, Box plot, the expression of C20orf54 mRNA was significantly higher in CSCC than that matched tissue(0.21±0.14 vs 0.16±0.12; n = 22, P<0.05). D, Bar chart for relative expression of C20orf54 protein in CSCC and matched tissue (0.93± 0.41 vs 0.80±0.36; n = 22) repeat three times in each sample,* indicates P<0.05, ☆indicates P<0.01).
Reference
Citation: The PLOS ONE Staff (2014) Correction: Association of the Plasma and Tissue Riboflavin Levels with C20orf54 Expression in Cervical Lesions and Its Relationship to HPV16 Infection. PLoS ONE 9(7): e103377. https://doi.org/10.1371/journal.pone.0103377
Published: July 16, 2014
Copyright: © 2014 The PLOS ONE Staff. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.